Leadgene Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 44

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 3

Leadgene General Information

Description

Developer of antibody-drug candidates and companion diagnostics intended to help with the development of monoclonal antibodies and antibody drugs. The company specializes in immuno-technology and especially in antigen prediction and design and the development of monoclonal antibodies and protein, develops application platforms, including IVD kit development and antibody drug development, as well as related reagents for both academic research and in vitro diagnostics use, thereby delivering the highest quality products and premium services for clinical studies.

Contact Information

Website
www.leadgenebio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 9, Lane 147, Zhengbei 1st Road
  • Yongkang District
  • Tainan, 710
  • Taiwan
+886 06
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Corporate Office
  • Number 9, Lane 147, Zhengbei 1st Road
  • Yongkang District
  • Tainan, 710
  • Taiwan
+886 06

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Leadgene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Jul-2026 Completed Generating Revenue
2. Later Stage VC 25-Oct-2023 Completed Generating Revenue
1. Early Stage VC 31-Mar-2015 Completed Generating Revenue
To view Leadgene’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Leadgene Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 4

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Leadgene Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3794029-A1 Compositions of isolated monoclonal antibodies and/or antigen-binding fragments thereof against indoxyl sulfate and uses thereof Pending 18-Apr-2018
EP-3794029-A4 Compositions of isolated monoclonal antibodies and/or antigen-binding fragments thereof against indoxyl sulfate and uses thereof Pending 18-Apr-2018
US-10723791-B2 Compositions of isolated monoclonal antibodies and/or antigen-binding fragments thereof against indoxyl sulfate and uses thereof Active 18-Apr-2018
US-20200031909-A1 Compositions of isolated monoclonal antibodies and/or antigen-binding fragments thereof against indoxyl sulfate and uses thereof Active 18-Apr-2018
WO-2019201311-A1 Compositions of isolated monoclonal antibodies and/or antigen-binding fragments thereof against indoxyl sulfate and uses thereof Inactive 18-Apr-2018 C07K16/18
To view Leadgene’s complete patent history, request access »

Leadgene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Leadgene Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Trinity Investment Corporation Venture Capital Minority
Darwin Venture Management Venture Capital Minority
National Development Fund of Taiwan Sovereign Wealth Fund Minority
To view Leadgene’s complete investors history, request access »

Leadgene Investments & Acquisitions (3)

Leadgene’s most recent deal was a Merger/Acquisition with Cytena Bioprocess Solutions. The deal was made on 03-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cytena Bioprocess Solutions 03-Oct-2025 Merger/Acquisition Discovery Tools (Healthcare)
Sidsco 02-Jan-2025 Merger/Acquisition Laboratory Services (Healthcare)
H2U Health 08-Feb-2024 Later Stage VC Application Software
To view Leadgene’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Leadgene Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Cytena Bioprocess Solutions Taipei, Taiwan 2018
Sidsco Taiwan 2018

Leadgene FAQs

  • When was Leadgene founded?

    Leadgene was founded in 2013.

  • Where is Leadgene headquartered?

    Leadgene is headquartered in Tainan, Taiwan.

  • What is the size of Leadgene?

    Leadgene has 44 total employees.

  • What industry is Leadgene in?

    Leadgene’s primary industry is Drug Discovery.

  • Is Leadgene a private or public company?

    Leadgene is a Private company.

  • What is Leadgene’s current revenue?

    The current revenue for Leadgene is .

  • Who are Leadgene’s investors?

    Trinity Investment Corporation, Darwin Venture Management, and National Development Fund of Taiwan have invested in Leadgene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process